Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation

doi:10.4254/wjh.v13.i6.673

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4659)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

313

WORD

222

HTML

1930

Figures (1-4)

308

Tables (1-3)

298

Sum=3071

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

658

Download

930

Sum=1588

Jun 27, 2021 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Jun 27, 2021; 13(6): 673-685
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.673

Full Size Figure Download Figure

Figure 4 Mean fluorescence intensity levels on graft survival. Kaplan-Meyer survival plot; vertical axis: Graft survival (decimal); horizontal axis: Duration of graft survival (months); graphs: Patients who have donor-specific antibodies (DSAs) with mean fluorescence intensity (MFI) above 1500 are shown in dark grey; numbers at risk n = 22; patients who have DSAs with MFI above 10000 are shown in green; numbers at risk n = 16. MFI: Mean fluorescence intensity.

Citation: Schotters FL, Beime J, Briem-Richter A, Binder T, Herden U, Grabhorn EF. Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation. World J Hepatol 2021; 13(6): 673-685
URL: https://www.wjgnet.com/1948-5182/full/v13/i6/673.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i6.673